NCT05244239View on ClinicalTrials.gov

Palliative Radiotherapy with Lurbinectedin in Patients with Extensive Stage Small Cell Lung Cancer

PHASE1RecruitingINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 27, 2022

Primary Completion Date

July 28, 2025

Study Completion Date

July 28, 2025

Conditions
Extensive Stage Lung Small Cell CarcinomaStage IV Lung Cancer AJCC V8
Interventions
DRUG

Lurbinectedin

Given IV

RADIATION

Palliative Radiation Therapy

Undergo RT

Trial Locations (3)

30308

NOT_YET_RECRUITING

Emory University Hospital Midtown, Atlanta

30322

RECRUITING

Emory University, Atlanta

30342

NOT_YET_RECRUITING

Emory Saint Joseph's Hospital, Atlanta

Sponsors

Collaborators (1)

Jazz Pharmaceuticals
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Jazz Pharmaceuticals

INDUSTRY

lead

Emory University

OTHER